Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course.

Journal of Crohn's & colitis - 1 Sept 2017

Smids Carolijn, Horjus Talabur Horje Carmen S, Nierkens Stefan, Drylewicz Julia, Groenen Marcel J M, Wahab Peter J, van Lochem Ellen G

Abstract excerpt

BACKGROUND AND AIMS: More than half of patients with Crohn's disease [CD] develop disease complications requiring aggressive medical therapy or surgery over time. However, predicting disease course and treatment response remains difficult. We therefore identified distinctive serum analytes associated with disease activity and course in newly diagnosed, untreated patients at presentation and during their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Crohn Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoassay

Share to Induction Chemotherapy

Share to Maintenance Chemotherapy

Share to Pilot Projects

Share to Prednisone

Share to Recurrence

Source

Identifiers

PMID: 28369318
DOI: 10.1093/ecco-jcc/jjx049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course.PMID 28369318Read ↗

The use of prognostic factors in inflammatory bowel diseases.Semantic proximity Read ↗

Clinical perspectives in Crohn's disease. Serologic and prognostic biomarkers: who, when, and how?Semantic proximity Read ↗

Clinical, serological and genetic predictors of inflammatory bowel disease course.Semantic proximity Read ↗

Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice.Semantic proximity Read ↗

Clinical predictors of Crohn's disease course.Semantic proximity Read ↗

Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study.Semantic proximity Read ↗

Evaluation of Capsule Endoscopy and Fecal Calprotectin for Risk Stratification in Asymptomatic Crohn’s Disease: A Prospective Observational StudySemantic proximity Read ↗

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?Semantic proximity Read ↗

Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy.Semantic proximity Read ↗

Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s diseaseSemantic proximity Read ↗

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesisSemantic proximity Read ↗

78 Longitudinal Status of Serological Markers Predict Crohn's Disease Phenotype Before Diagnosis: A ‘PREDICTS’ StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.